Loading clinical trials...
Loading clinical trials...
This is a multi-center study for the long-term follow-up of surviving patients who are expected to complete or who have completed at least two years of follow-up after treatment with Iodine I 131 Tosi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
GlaxoSmithKline
NCT02682667 · Multiple Myeloma, Lymphoma, Non-Hodgkin, and more
NCT01676805 · Hodgkin Disease, Lymphoma, Non-Hodgkin, and more
NCT06923397 · Lymphoma, Lymphoma, Hodgkin, and more
NCT06510361 · Lymphoma, Follicular Lymphoma, and more
NCT05442515 · B-NHL, B-Non Hodgkin Lymphoma, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions